CT Cardiomegaly vs AI-ECG Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Innolitics
VS
by Carewell Health

AI Verdict

While both are FDA-cleared AI tools designed to assist physicians in cardiology, their core functionalities and input data types are distinct. Tool A specializes in measuring cardiothoracic ratios from CT images for cardiomegaly detection, whereas Tool B focuses on the automatic analysis and diagnosis of 12-lead resting ECGs for a broader range of cardiovascular conditions. Therefore, they serve complementary roles within cardiology rather than being direct competitors for the same task.

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if your primary need is automated, quantitative assessment of heart size from CT chest images to aid in cardiomegaly detection. This tool is ideal for radiology departments or cardiology practices that regularly utilize CT scans and require precise, objective measurements of the cardiothoracic ratio for diagnostic support and reporting. Its command-line deployment makes it suitable for integration into existing imaging workflows.

View CT Cardiomegaly →

Choose AI-ECG Platform if…

Choose AI-ECG Platform if you require rapid, AI-powered automatic analysis and diagnosis of 12-lead resting ECGs for a broad spectrum of cardiovascular conditions. This platform is best suited for emergency medicine, internal medicine, or cardiology settings where quick and accurate interpretation of ECGs is critical for diagnosing arrhythmias, myocardial ischemia, and other cardiac abnormalities. Its hardware independence and various deployment options offer flexibility for integration into diverse clinical environments.

View AI-ECG Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CT Cardiomegaly AI-ECG Platform
Pricing Fixed-fee Unknown
Deployment Docker Container (Ubuntu 20.04), command-line software On-premise (AI-ECG Workstation), web-based (Management Portal), and client-based (AI-ECG Diagnostic Client).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-ECG Platform

Tool B offers a more user-friendly experience with a web-based portal and a Windows-based diagnostic client, catering to direct clinical use with graphical interfaces for review and report generation. Tool A, being a command-line software deployed via Docker, requires a higher technical proficiency, making it less accessible for typical clinical end-users.

Clinical Value

AI-ECG Platform

Tool B provides a broader range of diagnostic assistance for 12-lead resting ECGs, covering arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction with over 95% accuracy and rapid diagnosis. While Tool A offers valuable quantitative cardiothoracic ratio measurements from CT, Tool B's comprehensive diagnostic scope for a widely used test gives it a slight edge in overall clinical utility.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information, making a direct comparison of their cost-effectiveness impossible without further details. Both are FDA-cleared, indicating a baseline level of quality and regulatory compliance, but specific value propositions cannot be assessed.

Enterprise Readiness

AI-ECG Platform

Tool B demonstrates stronger enterprise readiness through its support for various standard ECG data formats (Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG) and a web-based management portal for organization settings and task management. This facilitates easier integration into existing hospital IT infrastructures and provides better administrative control compared to Tool A's command-line Docker deployment, despite Tool A's explicit HIPAA and BAA compliance.

Innovation

AI-ECG Platform

Both tools leverage AI for diagnostic assistance. Tool B's application of AI to provide rapid, comprehensive diagnoses across multiple cardiovascular conditions from a standard ECG, coupled with its hardware independence and broad data format support, represents a slightly broader and more impactful innovation in a widely used clinical context. Tool A's focus on a specific quantitative CT measurement is valuable but narrower in scope.

Support & Docs

AI-ECG Platform

Shenzhen Carewell Electronics (Tool B) appears to have a more established product support infrastructure, typical of a medical device manufacturer with a dedicated 'Support' section on its website, implying readily available user manuals and technical documentation. Innolitics (Tool A), while offering a valuable tool, seems to be a company more focused on AI/ML development and consulting, with less explicit product-specific support details readily available online.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CT Cardiomegaly AI-ECG Platform
Name CT Cardiomegaly AI-ECG Platform
Company Innolitics Shenzhen Carewell Electronics Co., Ltd.
Description Innolitics' CT Cardiomegaly is an FDA-cleared AI-powered command-line software that automatically measures cardiothoracic ratio from CT chest images, assisting physicians in cardiomegaly detection with quantitative data. The AI-ECG Platform by Shenzhen Carewell Electronics is an FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy.
Key Features Automatic cardiothoracic ratio measurement, Machine learning algorithms for segmentation, Segmentation of heart and thoracic cavity, Calculates linear and area-based cardiothoracic ratios, Outputs PDF and JSON reports, Command-line software tool, Non-adaptive machine learning using MONAI framework, Validated against manual measurements by board-certified radiologists AI-powered automatic ECG analysis and diagnosis, Over 95% accuracy in diagnosing major cardiovascular diseases, Diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, Hardware independent, compatible with most ECG machines, Web-based Management Portal for organization settings, security, and task management, AI-ECG Diagnostic Client for professional ECG review, waveform measurement, and report generation, Rapid diagnosis in approximately 3 seconds, Supports various ECG data formats: Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI
Specialties Cardiology, Radiology Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring CT Cardiomegaly and AI-ECG Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, Innolitics' CT Cardiomegaly, analyzes CT chest images to measure cardiothoracic ratio. Tool B, Shenzhen Carewell Electronics' AI-ECG Platform, analyzes 12-lead resting ECGs for automatic diagnosis.
CT Cardiomegaly assists in cardiomegaly detection by providing quantitative linear and area-based cardiothoracic ratio measurements from CT images. The AI-ECG Platform provides AI-powered automatic analysis and diagnosis of major cardiovascular diseases from ECGs, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
CT Cardiomegaly is a command-line software that outputs PDF and JSON reports. The AI-ECG Platform offers a web-based management portal and a Windows-based diagnostic client for professional ECG review and report generation, providing rapid diagnoses in approximately 3 seconds.
CT Cardiomegaly was validated against manual measurements performed by board-certified radiologists. The AI-ECG Platform reports over 95% accuracy in diagnosing major cardiovascular diseases.
Both CT Cardiomegaly and the AI-ECG Platform are FDA-cleared. CT Cardiomegaly explicitly states it is HIPAA compliant and typically offers a Business Associate Agreement (BAA), while the AI-ECG Platform states HIPAA compliance and BAA are likely.
AI Tool Finder
AI-powered search. Results may not be comprehensive.